Skip to content

Effect of Vibhitakadi Ghrita and Triphaladi compound orally and Rajnidaaru eye drops in Dry Eye Syndrome

â??Comparative evalaution of Vibhitakadi ghrita and Triphaladi compound orally alone and along with Rajnidaaru eye drops in Shushkakshipaka (Dry Eye Syndrome) - An open label double arm randomized clinical trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055133
Enrollment
28
Registered
2023-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex aged between 21 to 60 years. 2. Patient is willing and able to participate in the study. 3. Patients presenting with sign and symptoms of Dry eye syndrome and lakshana of Shushkakshipaka as described in the text.

Exclusion criteria

Exclusion criteria: 1. Severe cases of dry eye syndrome with complications like corneal ulcers, uveitis, glaucoma etc. 2. Allergic and inflammatory conditions of eye e.g., Acute Conjunctivitis, Vernal Keratoconjunctivitis, giant papillary conjunctivitis etc. 3. Patients on steroids, oral contraceptive pills, oestrogen replacement therapy, or any other medication such as antispasmodic drugs such as Atropine that may adversely affect the outcome of study. 4. Patients suffering from major systemic illness necessitating long term treatment ex. Psycho-epileptic drug users etc. 5. H/o hypersensitivity to the trial drug or any of its ingredients.

Design outcomes

Primary

MeasureTime frame
Change in foreign body sensation in Shushkakshipaka w.s.r. to Dry eye syndrome assessed through specific questionnaire & tools.Timepoint: 42 days

Secondary

MeasureTime frame
Changes in the quality of life will be assessed according to OSDI Chart.Timepoint: 42 days

Countries

India

Contacts

Public ContactDr Nancy Aggarwal
bhatrajma@gmail.com9560788850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026